Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (421-430 of 598) with videos related to

Pageof 60
Sort By:
Blood|December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Blood Cancer Journal|April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood Cancer Journal|May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Haematologica|July 10, 2025
The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemiaHelong Gary Zhao, Nataly Cruz-Rodriguez, Kent C Johnson, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
Leukemia|October 20, 2022
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasiaYasuo Kubota, Misam Zawit, Jibran Durrani, et al.
Nature Communications|February 25, 2022
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomesJakob Woerner, Yidi Huang, Stephan Hutter, et al.
Oncotarget|November 27, 2016
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in miceEva Gentner, Naidu M Vegi, Medhanie A Mulaw, et al.
Leukemia|March 14, 2021
Correction: complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Pageof 60

Showing results (421-430 of 598) with videos related to

Sort By:
Pageof 60
Blood|December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Blood Cancer Journal|April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood Cancer Journal|May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Haematologica|July 10, 2025
The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemiaHelong Gary Zhao, Nataly Cruz-Rodriguez, Kent C Johnson, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
Leukemia|October 20, 2022
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasiaYasuo Kubota, Misam Zawit, Jibran Durrani, et al.
Nature Communications|February 25, 2022
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomesJakob Woerner, Yidi Huang, Stephan Hutter, et al.
Oncotarget|November 27, 2016
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in miceEva Gentner, Naidu M Vegi, Medhanie A Mulaw, et al.
Leukemia|March 14, 2021
Correction: complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Pageof 60